EGb761 ameliorates cell necroptosis by attenuating RIP1-mediated mitochondrial dysfunction and ROS production in both in vivo and in vitro models of Alzheimer’s disease
EGb761 ameliorates cell necroptosis by attenuating RIP1-mediated mitochondrial dysfunction and ROS production in both in vivo and in vitro models of Alzheimer’s disease
复制标题
在阿尔茨海默病的体内和体外模型中,EGb761 通过减轻 RIP1 介导的线粒体功能障碍和 ROS 产生来改善细胞坏死性凋亡
DOI:
10.1016/j.brainres.2020.146730
复制
发表时间:
2020-02
期刊:
影响因子:
2.9
通讯作者:
Liu X
中科院分区:
文献类型:
--
作者:
Tu JL;Chen WP;Cheng ZJ;Zhang G;Luo QH;Li M;Liu X
ObjectivesTo investigate the neuroprotective effect of Gingko biloba extract 761 (EGb761) in Alzheimer’s disease (AD) models bothin vivoandin vitroand the underlying molecular mechanism.MethodsCultured BV2 microglial cells were treated with Aβ1-42to establish anin vitroAD model. Thein vivorat AD model was established by injecting Aβ1-42. Cells were pre-treated with EGb761, and the proliferation and necroptosis were examined by MTT or flow cytometry assays, respectively. In addition, the membrane potential and oxidative stress were measured. Cognitive function was evaluated by the Morris water maze, and the activation of the JNK signaling pathway was quantified by Western blotting.ResultsCultured BV2 cells exhibited prominent cell death after Aβ1-42induction, and this cell death was alleviated by EGb761 pre-treatment. EGb761 was found to relieve oxidative stress and suppress the membrane potential and calcium overload. EGb761 treatment in AD model rats also improved cognitive function deficits. Both cultured microglial cells and the rat hippocampus exhibited activation of the JNK signaling pathway, and EGb761 relieved this activation in cells.ConclusionOur results showed that EGb761 regulated cell proliferation, suppressed necroptosis and apoptosis, relieved mitochondrial damage, and ameliorated tissue damage to improve cognitive function in AD models. All of these effects may involve the suppression of the JNK signaling pathway.
登录
查看更多内容
DOI:
10.1016/j.cca.2015.01.026
发表时间:
2015-12-07
期刊:
Clinica chimica acta; international journal of clinical chemistry
影响因子:
--
作者:
Thornton C;Hagberg H
通讯作者:
Hagberg H
DOI:
--
发表时间:
2002
影响因子:
11.1
作者:
Yuan Luo;J. Smith;V. Paramasivam;Adam Burdick;K. Curry;Justin P Buford;I. Khan;William J. Netzer-William-J.
通讯作者:
Yuan Luo;J. Smith;V. Paramasivam;Adam Burdick;K. Curry;Justin P Buford;I. Khan;William J. Netzer-William-J.
影响因子:
16.6
作者:
Kucinski I;Dinan M;Kolahgar G;Piddini E
通讯作者:
Piddini E
影响因子:
15.1
作者:
Liu, Xu;Hao, Wenlin;Liu, Yang
通讯作者:
Liu, Yang
影响因子:
3.3
作者:
Meng, Xue-Lian;Chen, Chang-Lan;Lu, Jing
通讯作者:
Lu, Jing